CARsgen Therapeutics Holdings Ltd - ESG Rating & Company Profile powered by AI
This webpage of CARsgen Therapeutics Holdings Ltd is assembled by All Street Sevva using leading NLP. Other corporations in the rating peer group for CARsgen Therapeutics Holdings Ltd are shownin the table. This analysis of CARsgen Therapeutics Holdings Ltd uses data from across the internet as well as from available documents by CARsgen Therapeutics Holdings Ltd.
CARsgen Therapeutics Holdings Ltd in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 4.5; made up of an environmental score of 4.0, social score of 4.8 and governance score of 4.8.
4.5
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| 852 | Vaccibody AS | 4.6 | High |
| 852 | argenx SE | 4.6 | High |
| 868 | CARsgen Therapeutics Holdings Ltd | 4.5 | High |
| 868 | Boiron SA | 4.5 | High |
| 868 | Bonesupport Holding AB | 4.5 | High |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does CARsgen Therapeutics Holdings Ltd have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes CARsgen Therapeutics Holdings Ltd disclose current and historical energy intensity?
Sign up for free to unlockDoes CARsgen Therapeutics Holdings Ltd report the average age of the workforce?
Sign up for free to unlockDoes CARsgen Therapeutics Holdings Ltd reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes CARsgen Therapeutics Holdings Ltd disclose its ethnicity pay gap?
Sign up for free to unlockDoes CARsgen Therapeutics Holdings Ltd disclose cybersecurity risks?
Sign up for free to unlockDoes CARsgen Therapeutics Holdings Ltd offer flexible work?
Sign up for free to unlockDoes CARsgen Therapeutics Holdings Ltd have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes CARsgen Therapeutics Holdings Ltd disclose the number of employees in R&D functions?
Sign up for free to unlockDoes CARsgen Therapeutics Holdings Ltd conduct supply chain audits?
Sign up for free to unlockDoes CARsgen Therapeutics Holdings Ltd disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes CARsgen Therapeutics Holdings Ltd conduct 360 degree staff reviews?
Sign up for free to unlockDoes CARsgen Therapeutics Holdings Ltd disclose the individual responsible for D&I?
Sign up for free to unlockDoes CARsgen Therapeutics Holdings Ltd disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes CARsgen Therapeutics Holdings Ltd disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes CARsgen Therapeutics Holdings Ltd disclose water use targets?
Sign up for free to unlockDoes CARsgen Therapeutics Holdings Ltd have careers partnerships with academic institutions?
Sign up for free to unlockDid CARsgen Therapeutics Holdings Ltd have a product recall in the last two years?
Sign up for free to unlockDoes CARsgen Therapeutics Holdings Ltd disclose incidents of discrimination?
Sign up for free to unlockDoes CARsgen Therapeutics Holdings Ltd allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas CARsgen Therapeutics Holdings Ltd issued a profit warning in the past 24 months?
Sign up for free to unlockDoes CARsgen Therapeutics Holdings Ltd disclose parental leave metrics?
Sign up for free to unlockDoes CARsgen Therapeutics Holdings Ltd disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes CARsgen Therapeutics Holdings Ltd disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes CARsgen Therapeutics Holdings Ltd disclose the pay ratio of women to men?
Sign up for free to unlockDoes CARsgen Therapeutics Holdings Ltd support suppliers with sustainability related research and development?
Sign up for free to unlockDoes CARsgen Therapeutics Holdings Ltd disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes CARsgen Therapeutics Holdings Ltd reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs CARsgen Therapeutics Holdings Ltd involved in embryonic stem cell research?
Sign up for free to unlockDoes CARsgen Therapeutics Holdings Ltd disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes CARsgen Therapeutics Holdings Ltd disclose its waste policy?
Sign up for free to unlockDoes CARsgen Therapeutics Holdings Ltd report according to TCFD requirements?
Sign up for free to unlockDoes CARsgen Therapeutics Holdings Ltd disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes CARsgen Therapeutics Holdings Ltd disclose energy use targets?
Sign up for free to unlockDoes CARsgen Therapeutics Holdings Ltd disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes CARsgen Therapeutics Holdings Ltd have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for CARsgen Therapeutics Holdings Ltd
These potential risks are based on the size, segment and geographies of the company.
CARsgen Therapeutics Holdings Limited, a biopharmaceutical company, engages in discovering, developing, and commercializing chimeric antigen receptor T (CAR-T) cell therapies for the treatment of hematological malignancies and solid tumors in China and the United States. The company is involved in developing CT053, an autologous CAR-T product candidate that is in pivotal Phase II trial for the treatment of relapsed/refractory multiple myeloma in China; CT041, an autologous CAR-T product candidate that is in Phase Ib/II clinical trial for advanced gastric/gastroesophageal junction cancer and pancreatic cancer in China, as well as in Phase Ib clinical trial for advanced gastric or pancreatic cancer in the United States; and CT011, an autologous CAR-T product candidate that is in Phase I clinical trial for patients with Glypican-3 positive advanced hepatocellular carcinoma. It is also developing CT032, an autologous CAR-T products candidate that is in Phase I/II clinical trial for the treatment of B cell Non-Hodgkin's lymphoma in China; AB011, a humanized monoclonal antibody product candidate that is in Phase I clinical trial for the treatment of CLDN18.2 positive solid tumors in China; and CT017, an autologous Glypican-3-targeted CAR-T product candidate for the treatment of hepatocellular carcinoma, as well as other product candidates for the treatment of solid tumors. The company was founded in 2014 and is headquartered in Shanghai, China.